Immunotherapy for anti-GQ1b IgG antibody-mediated disorders: role of electrophysiology in human trials.
Lo
Y-L
YL
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001323:Autoantibodies / Q000097:blood*; D055724:Electrophysiological Phenomena; D005732:Gangliosides / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D051379:Mice; D019846:Miller Fisher Syndrome / Q000628:therapy*; D020721:Nervous System Autoimmune Disease, Experimental / Q000628:therapy*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001323:Autoantibodies; D005732:Gangliosides; D007074:Immunoglobulin G; C039129:GQ1b ganglioside; C481642:eculizumab